On the contrary, a recent study revealed the upregulation of Axl after abrogation of ADAMTSL5, a crucial regulator of oncogenic signaling and chemoresistance in HCC, suggesting a role in the acquisition of chemosensitivity rather than in its escape from drug treatment [52]. The gene discussed is AXL; the disease is hepatocellular carcinoma.